A patent review of FGFR4 selective inhibition in cancer (2007-2018)

Volume 29, Issue 6, June 2019, Page 429-438 .
Source: Expert Opinion on Therapeutic Patents - Category: Drugs & Pharmacology Authors: Source Type: research